Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Anticoagulant | Case report

Cerebral vein thrombosis in a woman using oral contraceptive pills for a short period of time: a case report

Authors: Somayeh Moeindarbari, Nazanin Beheshtian, Shima Hashemi

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Cerebral vein thrombosis is increasing in young adults. Although oral contraceptive pills increase the risk of cerebral vein thrombosis, relatively high brain venous involvement is rare when oral contraceptive pills are consumed for a short duration.

Case presentation

A 31-year-old Asian woman was referred to Imam Reza Hospital with a headache complaint on 11 November 2020. The woman, who had a headache for the previous 11 days, went to the hospital. Owing to endometriosis involvement, she consumed Diane tablets. According to the imaging findings, three vein involvements were diagnosed. Anticoagulant therapy was started, and the symptoms disappeared.

Conclusions

All cerebral vein thrombosis symptoms are variable, but new presentation of headache could be an early symptom of cerebral vein thrombosis.
Literature
1.
go back to reference Khomand P, Hassanzadeh K. A case-series study of cerebral venous thrombosis in women using short course oral contraceptive. Iran J Neurol. 2016;15(2):92.PubMedPubMedCentral Khomand P, Hassanzadeh K. A case-series study of cerebral venous thrombosis in women using short course oral contraceptive. Iran J Neurol. 2016;15(2):92.PubMedPubMedCentral
2.
go back to reference Ferro JM, Canhão P, de Sousa DA. Cerebral venous thrombosis. La Presse Médicale. 2016;45(12):e429–50.CrossRef Ferro JM, Canhão P, de Sousa DA. Cerebral venous thrombosis. La Presse Médicale. 2016;45(12):e429–50.CrossRef
3.
go back to reference Ferro JM, Bousser M-G, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis–endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195–221.CrossRef Ferro JM, Bousser M-G, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis–endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195–221.CrossRef
4.
go back to reference Uemura M, Tsukamoto Y, Akaiwa Y, Watanabe M, Tazawa A, Kasahara S, et al. Cerebral venous sinus thrombosis due to oral contraceptive use: postmortem 3 T-MRI and autopsy findings. Hum Pathol Case Rep. 2016;6:32–6.CrossRef Uemura M, Tsukamoto Y, Akaiwa Y, Watanabe M, Tazawa A, Kasahara S, et al. Cerebral venous sinus thrombosis due to oral contraceptive use: postmortem 3 T-MRI and autopsy findings. Hum Pathol Case Rep. 2016;6:32–6.CrossRef
5.
go back to reference Merz M, Kroll R, Lynen R, Bangerter K. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Contraception. 2015;91(2):113–20.CrossRef Merz M, Kroll R, Lynen R, Bangerter K. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Contraception. 2015;91(2):113–20.CrossRef
7.
go back to reference Matsushima T, Akira S, Asakura H, Takeshita T. Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use. Clin Exp Obstet Gynecol. 2017;44(1):143–5.CrossRef Matsushima T, Akira S, Asakura H, Takeshita T. Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use. Clin Exp Obstet Gynecol. 2017;44(1):143–5.CrossRef
8.
go back to reference Silvis S, Hiltunen S, Lindgren E, Jood K, Zuurbier S, Middeldorp S, et al. Cancer and risk of cerebral venous thrombosis: a case–control study. J Thromb Haemost. 2018;16(1):90–5.CrossRef Silvis S, Hiltunen S, Lindgren E, Jood K, Zuurbier S, Middeldorp S, et al. Cancer and risk of cerebral venous thrombosis: a case–control study. J Thromb Haemost. 2018;16(1):90–5.CrossRef
9.
go back to reference Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Research. 2016;5:186.CrossRef Nothnick W, Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Research. 2016;5:186.CrossRef
10.
go back to reference Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015;350:h2135.CrossRef Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015;350:h2135.CrossRef
11.
go back to reference Saadatnia M, Tajmirriahi M. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand. 2007;115(5):295–300.CrossRef Saadatnia M, Tajmirriahi M. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis. Acta Neurol Scand. 2007;115(5):295–300.CrossRef
12.
go back to reference Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Hu FB, Manson JE. Exogenous hormone use: oral contraceptives, postmenopausal hormone therapy, and health outcomes in the Nurses’ Health Study. Am J Public Health. 2016;106(9):1631–7.CrossRef Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Hu FB, Manson JE. Exogenous hormone use: oral contraceptives, postmenopausal hormone therapy, and health outcomes in the Nurses’ Health Study. Am J Public Health. 2016;106(9):1631–7.CrossRef
13.
go back to reference Roethlisberger M, Gut L, Zumofen DW, Fisch U, Boss O, Maldaner N, et al. Cerebral venous thrombosis requiring invasive treatment for elevated intracranial pressure in women with combined hormonal contraceptive intake: risk factors, anatomical distribution, and clinical presentation. Neurosurg Focus. 2018;45(1):E12.CrossRef Roethlisberger M, Gut L, Zumofen DW, Fisch U, Boss O, Maldaner N, et al. Cerebral venous thrombosis requiring invasive treatment for elevated intracranial pressure in women with combined hormonal contraceptive intake: risk factors, anatomical distribution, and clinical presentation. Neurosurg Focus. 2018;45(1):E12.CrossRef
14.
go back to reference Dunselman G, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12.CrossRef Dunselman G, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12.CrossRef
15.
go back to reference Panos GD, Panos LD, Digklia A, Hafezi F, Gatzioufas Z. Unusual presentation of cerebral venous sinus thrombosis associated with contraceptive usage. J Ophthalmic Vis Res. 2014;9(2):281.PubMedPubMedCentral Panos GD, Panos LD, Digklia A, Hafezi F, Gatzioufas Z. Unusual presentation of cerebral venous sinus thrombosis associated with contraceptive usage. J Ophthalmic Vis Res. 2014;9(2):281.PubMedPubMedCentral
Metadata
Title
Cerebral vein thrombosis in a woman using oral contraceptive pills for a short period of time: a case report
Authors
Somayeh Moeindarbari
Nazanin Beheshtian
Shima Hashemi
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03473-w

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue